India
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
28.48%
|
March 31, 2024 | USD 9.86 | 2.71% |
|
India |
|
2 |
25.69%
|
March 31, 2024 | USD 22.79 | -0.22% |
|
India |
|
3 |
21.30%
|
March 31, 2024 | USD 13.51 | -1.02% |
|
India |
|
4 |
19.13%
|
March 31, 2024 | USD 22.57 | -4.38% |
|
India |
|
5 |
9.60%
|
March 31, 2024 | USD 16.75 | 0.23% |
|
India |
|
6 |
7.43%
|
March 31, 2024 | USD 3.94 | 4.92% |
|
India |
|
7 |
3.87%
|
March 31, 2024 | USD 16.33 | 9.92% |
|
India |
The Vaccines company in India with the highest EBITDA Margin is Vimta Labs Limited (NSE: VIMTALABS.NS) at 28.48%.
The Vaccines company in India with the lowest EBITDA Margin is Wockhardt Limited (NSE: WOCKPHARMA.NS) at 3.87%.
The top 10 Vaccines companies in India by EBITDA Margin are Vimta Labs Limited, GlaxoSmithKline Pharmaceuticals Limited, Aurobindo Pharma Limited, Hester Biosciences Limited, Glenmark Pharmaceuticals Limited, Panacea Biotec Limited and Wockhardt Limited.
The bottom 10 Vaccines companies in India by EBITDA Margin are Wockhardt Limited, Panacea Biotec Limited, Glenmark Pharmaceuticals Limited, Hester Biosciences Limited, Aurobindo Pharma Limited, GlaxoSmithKline Pharmaceuticals Limited and Vimta Labs Limited.